Jed Dean

Background

Jed Dean is a Venture Partner at Bee Partners, where he focuses on the convergence of artificial intelligence and synthetic biology. He is co-founder of Zymergen, the AI-powered biotech company (IPO 2021), and previously worked at Amyris and the Stanford Genome Technology Center. He studied at Stanford University School of Medicine and has also worked in advisory capacity at Essential Capital. At Bee he sources investment opportunities and identifies trends across the Biological Machines vector.

Investment Focus